FDA Import Refusal 1FX-4500417-4/30003/1 — WEDERM PRIVATE LIMITED

WEDERM PRIVATE LIMITED — FEI 3042590747

The FDA refused shipment 1FX-4500417-4/30003/1 from WEDERM PRIVATE LIMITED (India) on September 24, 2026. The refused product falls under Drugs and Biologics — EMPAGLIFLOZIN (ANTI-DIABETIC). Cited charges: 118,75 This firm has 4 other import refusals on record.

Refusal Details

Date
September 24, 2026
Country
India
Product Category
Drugs and Biologics
Product Code
61PCA73 EMPAGLIFLOZIN (ANTI-DIABETIC)
Charges
118,75